Biblio
Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol. 2021;41:101921.
. Role of induced pluripotent stem cells in lysosomal storage diseases. Mol Cell Neurosci. 2020:103540.
. New Type of Sendai Virus Vector Provides Transgene-Free iPS Cells Derived from Chimpanzee Blood. PLoS One. 2014;9(12):e113052.
Mesenchymal stem cells derived from human iPS cells via mesoderm and neuroepithelium have different features and therapeutic potentials. PLoS One. 2018;13(7):e0200790.
. HPGCD Outperforms HPBCD as A Potential Treatment for Niemann-Pick Disease Type C During disease Modeling with iPS Cells. Stem Cells. 2014.
Generation of a human induced pluripotent stem cell line, BRCi009-A, derived from a patient with glycogen storage disease type 1a. Stem Cell Res. 2020;49:102095.
Efficient and Reproducible Myogenic Differentiation from Human iPS Cells: Prospects for Modeling Miyoshi Myopathy In Vitro. PLoS One. 2013;8(4):e61540.
Disease modeling and lentiviral gene transfer in patient-specific induced pluripotent stem cells from late-onset Pompe disease patient. Mol Ther Methods Clin Dev. 2015;2:15023.
. .